4//SEC Filing
Javitt Jonathan C 4
Accession 0001415889-22-012324
CIK 0001719406other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:33 PM ET
Size
6.7 KB
Accession
0001415889-22-012324
Insider Transaction Report
Form 4
Javitt Jonathan C
DirectorChairman and Chief Scientist10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2022-12-07$1.00/sh−400,000$400,000→ 12,899,997 total(indirect: By Trust)
Holdings
- 146,332
Common Stock, par value $0.001 per share
- 1,422,000(indirect: By Trust)
Common Stock, par value $0.001 per share
Footnotes (3)
- [F1]Private sale pursuant to an option granted by the Reporting Person in 2017 in support of a financing for NeuroRx, Inc. Purchaser has agreed to hold the shares for a period of one year.
- [F2]Held by the Jonathan Javitt Living Trust. The Reporting Person is a trustee of the Trust.
- [F3]Held by the Javitt 2012 Irrevocable Dynasty Trust. The Reporting Person is the grantor of the Trust.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001303782
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:33 PM ET
- Size
- 6.7 KB